Subscribe to WNN emails About Contact

Related Topic: Radioisotopes

Canadian Candu produces cancer therapy isotope

Canadian Candu produces cancer therapy isotope

Lutetium-177 has been produced using a new isotope production system that was installed in unit 7 of the Bruce plant in Ontario, Canada, during a recent planned maintenance outage. It marks the first time the short-lived medical isotope has been produced in a commercial nuclear power reactor.

Corporate 22 June 2022

PULSAR project to research nuclear technology for Europe's space missions

PULSAR project to research nuclear technology for Europe's space missions

Tractebel will lead the PULSAR consortium conducting research on dynamic radioisotope power systems fuelled by plutonium-238 for space applications - to provide spacecraft and astronauts with electricity and heat when the sun does not supply enough power.

New Nuclear 21 June 2022

Most Read

Bruce Power harvests cobalt-60 to sterilise medical equipment

Canadian Candu produces cancer therapy isotope

Framatome and Exelon to explore Co-60 production

New isotope initiatives address supply challenges

New nuclear medicine facilities announced for Australia

NNL breakthrough to boost medical radioisotope supply

Novel method cuts isotope production waste

PULSAR project to research nuclear technology for Europe's space missions

South Africa seeks proposals for new research reactor

NNL breakthrough to boost medical radioisotope supply

NNL breakthrough to boost medical radioisotope supply

Scientists at the UK's National Nuclear Laboratory have developed a process for producing the country's first domestically produced supply of the medical radioisotope lead-212.

Regulation & Safety 31 May 2022

Novel method cuts isotope production waste

Novel method cuts isotope production waste

A new method to extract molybdenum-99 from low-enriched uranium targets, developed by researchers at the Technical University of Munich, could significantly reduce the radioactive waste produced during the production of the isotope. Mo-99 is the precursor for medical radioisotope technetium-99m, used in more than 85% of all nuclear medicine diagnostic examinations.

Waste & Recycling 01 April 2022

Belgian regulators OK isotope residue facility

Belgian regulators OK isotope residue facility

Belgium's SCK-CEN nuclear research centre has received all the licences needed for the construction and operation of a facility to support the RECUMO project to manage and recycle radioactive residues from the production of medical radioisotopes.

Waste & Recycling 04 March 2022

South Africa seeks proposals for new research reactor

South Africa seeks proposals for new research reactor

Necsa - the South African Nuclear Energy Corporation - has released a Request for Information for the Multipurpose Reactor to replace the 56-year-old Safari-1 research reactor located at Pelindaba.

New Nuclear 07 February 2022

Financing in place for European SHINE isotope plant

Financing in place for European SHINE isotope plant

SHINE Technologies of the USA has announced its European subsidiary, SHINE Europe, has secured funding to begin designing an advanced medical isotope production facility at Veendam in the Netherlands. 

New Nuclear 02 February 2022

MARIA steps in to maintain Mo-99 supplies

MARIA steps in to maintain Mo-99 supplies

Poland's only operating research reactor - the MARIA reactor at the National Centre for Nuclear Research in Świerk - has been able to rapidly rearrange its work schedule to respond to a shortage of the medical isotope molybdenum-99 due to a fault at the High Flux Reactor in the Netherlands.

Corporate 31 January 2022

Bruce 7 prepares for isotope production

Bruce 7 prepares for isotope production

Bruce unit 7 has become the first nuclear power reactor in the world with installed capability to produce the medical radioisotope lutetium-177. The isotope, which is used in the treatment of cancers such as neuroendocrine tumours and prostate cancer, will be produced from ytterbium targets irradiated in the reactor.

Regulation & Safety 25 January 2022

Bruce Power harvests cobalt-60 to sterilise medical equipment

Bruce Power harvests cobalt-60 to sterilise medical equipment

Enough cobalt-60 to sterilise 10 billion items of medical equipment was recently shipped from unit 7 at Canada's Bruce nuclear power plant. Meanwhile, a new production base for medical radioisotopes is being set up at the Qinshan Phase III nuclear power plant in China.

Corporate 10 January 2022